Delivery Order SPE2DB20D6035-SPE2DB23FD2GM
- Not listed
- The Defense Logistics Agency awarded a $29,314.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200-300mg doses of the antiretroviral medication emtricitabine-tenofovir. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 25, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor. This delivery...
- The Defense Logistics Agency awarded a $776.48 delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir disoproxil fumarate tablets in unit-of-use packaging of 30 tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price arrangement, with work scheduled for completion by September 25, 2023. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill...
- The Defense Logistics Agency awarded a $4,151.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of a 30-day supply of the HIV medication to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with no mention of major...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,385 to Amerisourcebergen Drug Corporation for 200-300mg tablets of emtricitabine-tenofovir. The delivery order, issued under an unspecified governmentwide acquisition contract, calls for 30 units of the antiretroviral medication to be delivered to a facility in Conshohocken, Pennsylvania between July 17-18, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,897.59 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by November 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,375.23 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive procurement under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,346.16 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,351.51 to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir combination tablets. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 20, 2023 in support of the Defense Logistics Agency's logistics and procurement missions. As the prime contractor, Amerisourcebergen Drug Corporation will utilize...
- The Defense Logistics Agency awarded a $3,218.90 delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The firm fixed price order is for 30 units of the HIV medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023 to support DLA programs. No set aside designation or subcontractors were identified. The order was placed under an existing DLA pharmaceutical supply vehicle to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units, with a ceiling value of $2,163.30. This delivery order is issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award authority. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB23FD2GMDelivery Order
The Defense Logistics Agency awarded a $3,660.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300 milligram doses of emtricitabine-tenofovir combination medication in 30-count unit packages. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on September 1, 2023. No additional details were provided regarding the original solicitation requirements or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle. Amerisourcebergen will serve as the prime contractor without involvement of announced major subcontractors in fulfilling this contract to supply antiretroviral medications in support of the Defense Logistics Agency's logistics and procurement missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/31/23 |